Your Article Summary
See Latest ArticlesAtosiban versus betamimetics in the treatment of preterm labour in Germany: an economic evaluation
BMC Pregnancy and Childbirth, 06/22/09
Wex J et al. - In a German setting, atosiban is cost saving versus betamimetics in the treatment of preterm labour from the payer, hospital and combined perspectives. Cost savings stem from the superior safety profile of atosiban.
Related Articles
A role for IL-17 in induction of an inflammation at the fetomaternal interface in preterm labour
Journal of Reproductive Immunology, 12/04/09
Relevance Score: 67%
Advances in foetal therapy
Obstetrics, Gynaecology & Reproductive Medicine, 11/16/09
Relevance Score: 64%
Maternal periodontal disease and preterm or extreme preterm birth: an ordinal logistic regression analysis
Journal of Periodontology, 12/03/09
Relevance Score: 46%
Systematic review of progesterone for the prevention of preterm birth in singleton pregnancies
Acta Obstetricia et Gynecologica Scandinavica, 11/16/09
Relevance Score: 45%
Academic, Social, and Behavioral Outcomes at Age 12 of Infants Born Preterm
Western Journal of Nursing Research, 11/04/09
Relevance Score: 45%
Today in Pharmacoeconomics...keeping you current
Receive free subspecialty "5-minute updates" via email
Costs of hospital-based methadone maintenance treatment in HIV/AIDS control among injecting drug users in Indonesia
Health Policy, 12/16/09
Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis
Cost Effectiveness and Resource Allocation, 12/15/09
Cost-effectiveness of single agent, uptitration and switching statin treatment strategies for lipid lowering in Sweden
Current Medical Research and Opinion, 12/14/09